{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:05:54Z","timestamp":1788602754440,"version":"build-2803163510"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41390-020-01218-3","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T14:02:35Z","timestamp":1603720955000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cholesterol metabolism and brain injury in neonatal encephalopathy"],"prefix":"10.1038","volume":"90","author":[{"given":"Amanda M.","family":"Dave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Peeples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk, J. J., White-Koning, M. & Badawi, N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum. Dev. 86, 329\u2013338 (2010).","journal-title":"Early Hum. Dev."},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1053\/j.nainr.2011.07.004","volume":"11","author":"KA Allen","year":"2011","unstructured":"Allen, K. A. & Brandon, D. H. Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments. Newborn Infant Nurs. Rev. 11, 125\u2013133 (2011).","journal-title":"Newborn Infant Nurs. Rev."},{"key":"1218_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar, M. & Weiss, M. D. Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 169, 397\u2013403 (2015).","journal-title":"JAMA Pediatr."},{"key":"1218_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-0029-1243175","volume":"40","author":"Z Yu","year":"2009","unstructured":"Yu, Z. et al. Hypoxia-ischemia brain damage disrupts brain cholesterol homeostasis in neonatal rats. Neuropediatrics 40, 179\u2013185 (2009).","journal-title":"Neuropediatrics"},{"key":"1218_CR5","doi-asserted-by":"crossref","unstructured":"Bruns, N. et al. Application of an Amplitude-integrated EEG Monitor (Cerebral Function Monitor) to neonates. J. Vis. Exp. 127, (2017).","DOI":"10.3791\/55985"},{"key":"1218_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/jp.2017.14","volume":"37","author":"M Chandrasekaran","year":"2017","unstructured":"Chandrasekaran, M., Chaban, B., Montaldo, P. & Thayyil, S. Predictive value of amplitude-integrated EEG (aEEG) after rescue hypothermic neuroprotection for hypoxic ischemic encephalopathy: a meta-analysis. J. Perinatol. 37, 684\u2013689 (2017).","journal-title":"J. Perinatol."},{"key":"1218_CR7","doi-asserted-by":"publisher","first-page":"e0165744","DOI":"10.1371\/journal.pone.0165744","volume":"11","author":"R Del R\u00edo","year":"2016","unstructured":"Del R\u00edo, R. et al. Amplitude integrated electroencephalogram as a prognostic tool in neonates with hypoxic-ischemic encephalopathy: a systematic review. PLoS ONE 11, e0165744 (2016).","journal-title":"PLoS ONE"},{"key":"1218_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/STROKEAHA.118.023167","volume":"50","author":"DG Hackam","year":"2019","unstructured":"Hackam, D. G. & Hegele, R. A. Cholesterol lowering and prevention of stroke. Stroke 50, 537\u2013541 (2019).","journal-title":"Stroke"},{"key":"1218_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/089771503767869953","volume":"20","author":"AD Kay","year":"2003","unstructured":"Kay, A. D. et al. Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury. J. Neurotrauma 20, 717\u2013723 (2003).","journal-title":"J. Neurotrauma"},{"key":"1218_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2010.02.140","volume":"396","author":"I Bj\u00f6rkhem","year":"2010","unstructured":"Bj\u00f6rkhem, I. & Hansson, M. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem. Biophys. Res. Commun. 396, 46\u201349 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1218_CR11","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1073\/pnas.95.14.8181","volume":"95","author":"BU Fitzky","year":"1998","unstructured":"Fitzky, B. U. et al. Mutations in the Delta7-sterol reductase gene in patients with the Smith\u2013Lemli\u2013Opitz syndrome. Proc. Natl Acad. Sci. USA 95, 8181\u20138186 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1218_CR12","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/pr.2018.49","volume":"83","author":"F Lu","year":"2018","unstructured":"Lu, F. et al. Upregulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain. Pediatr. Res. 83, 1218\u20131227 (2018).","journal-title":"Pediatr. Res."},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0168-0102(03)00100-7","volume":"46","author":"MR Ramirez","year":"2003","unstructured":"Ramirez, M. R. et al. Neonatal hypoxia-ischemia reduces ganglioside, phospholipid and cholesterol contents in the rat hippocampus. Neurosci. Res. 46, 339\u2013347 (2003).","journal-title":"Neurosci. Res."},{"key":"1218_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang, J. & Liu, Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell 6, 254\u2013264 (2015).","journal-title":"Protein Cell"},{"key":"1218_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11745-015-4096-7","volume":"51","author":"PAS Alphonse","year":"2016","unstructured":"Alphonse, P. A. S. & Jones, P. J. H. Revisiting human cholesterol synthesis and absorption: the reciprocity paradigm and its key regulators. Lipids 51, 519\u2013536 (2016).","journal-title":"Lipids"},{"key":"1218_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/BC.2009.035","volume":"390","author":"JM Dietschy","year":"2009","unstructured":"Dietschy, J. M. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol. Chem. 390, 287\u2013293 (2009).","journal-title":"Biol. Chem."},{"key":"1218_CR17","first-page":"132","volume":"22","author":"M-Y Sun","year":"2016","unstructured":"Sun, M.-Y. et al. 24(S)-Hydroxycholesterol as a modulator of neuronal signaling and survival. Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry 22, 132\u2013144 (2016).","journal-title":"Neurosci. Rev. J. Bringing Neurobiol. Neurol. Psychiatry"},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1021\/acschemneuro.9b00248","volume":"10","author":"TC Genaro-Mattos","year":"2019","unstructured":"Genaro-Mattos, T. C. et al. Cholesterol biosynthesis and uptake in developing neurons. ACS Chem. Neurosci. 10, 3671\u20133681 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"1218_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.plipres.2013.09.002","volume":"52","author":"EJ Zerenturk","year":"2013","unstructured":"Zerenturk, E. J., Sharpe, L. J., Ikonen, E. & Brown, A. J. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis. Prog. Lipid Res. 52, 666\u2013680 (2013).","journal-title":"Prog. Lipid Res."},{"key":"1218_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1096\/fj.12-211235","volume":"27","author":"M Jansen","year":"2013","unstructured":"Jansen, M. et al. What dictates the accumulation of desmosterol in the developing brain? FASEB J. 27, 865\u2013870 (2013).","journal-title":"FASEB J."},{"key":"1218_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/STROKEAHA.115.010810","volume":"47","author":"M Hern\u00e1ndez-Jim\u00e9nez","year":"2016","unstructured":"Hern\u00e1ndez-Jim\u00e9nez, M. et al. Seladin-1\/DHCR24 is neuroprotective by associating EAAT2 glutamate transporter to lipid rafts in experimental stroke. Stroke 47, 206\u2013213 (2016).","journal-title":"Stroke"},{"key":"1218_CR22","doi-asserted-by":"publisher","first-page":"27436","DOI":"10.1074\/jbc.M704976200","volume":"282","author":"AD Nguyen","year":"2007","unstructured":"Nguyen, A. D., McDonald, J. G., Bruick, R. K. & DeBose-Boyd, R. A. Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of insigs. J. Biol. Chem. 282, 27436\u201327446 (2007).","journal-title":"J. Biol. Chem."},{"key":"1218_CR23","first-page":"227","volume":"6","author":"J Dorszewska","year":"2000","unstructured":"Dorszewska, J. & Adamczewska-Goncerzewicz, Z. Patterns of free and esterified sterol fractions of the cerebral white matter in severe and moderate experimental hypoxia. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 6, 227\u2013231 (2000).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"1218_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0940-2993(97)80060-7","volume":"49","author":"M Wender","year":"1997","unstructured":"Wender, M., Adamczewska-Goncerzewicz, Z., Doroszewska, J. & Szczech, J. Free sterols in the rat white matter following experimental global ischemia. Exp. Toxicol. Pathol. 49, 57\u201359 (1997).","journal-title":"Exp. Toxicol. Pathol."},{"key":"1218_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1089\/neu.2007.0444","volume":"25","author":"CM Cartagena","year":"2008","unstructured":"Cartagena, C. M. et al. Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. J. Neurotrauma 25, 1087\u20131098 (2008).","journal-title":"J. Neurotrauma"},{"key":"1218_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.12.080","volume":"1319","author":"CM Cartagena","year":"2010","unstructured":"Cartagena, C. M., Burns, M. P. & Rebeck, G. W. 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury. Brain Res. 1319, 1\u201312 (2010).","journal-title":"Brain Res."},{"key":"1218_CR27","doi-asserted-by":"crossref","unstructured":"Lu, F. et al. Serum 24S-hydroxycholesterol predicts long-term brain structural and functional outcomes after hypoxia-ischemia in neonatal mice. J. Cereb. Blood Flow Metab. 271678X20911910 (2020).","DOI":"10.1177\/0271678X20911910"},{"key":"1218_CR28","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bj\u00f6rkhem","year":"1998","unstructured":"Bj\u00f6rkhem, I. et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39, 1594\u20131600 (1998).","journal-title":"J. Lipid Res."},{"key":"1218_CR29","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/bph.13007","volume":"172","author":"CM Emnett","year":"2015","unstructured":"Emnett, C. M. et al. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel. Br. J. Pharm. 172, 1333\u20131347 (2015).","journal-title":"Br. J. Pharm."},{"key":"1218_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biochi.2018.04.026","volume":"153","author":"S Grayaa","year":"2018","unstructured":"Grayaa, S. et al. Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders. Biochimie 153, 80\u201385 (2018).","journal-title":"Biochimie"},{"key":"1218_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neulet.2013.09.003","volume":"555","author":"I Bj\u00f6rkhem","year":"2013","unstructured":"Bj\u00f6rkhem, I. et al. Oxysterols and Parkinson\u2019s disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease. Neurosci. Lett. 555, 102\u2013105 (2013).","journal-title":"Neurosci. Lett."},{"key":"1218_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3940(02)00887-X","volume":"331","author":"V Leoni","year":"2002","unstructured":"Leoni, V. et al. Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis. Neurosci. Lett. 331, 163\u2013166 (2002).","journal-title":"Neurosci. Lett."},{"key":"1218_CR33","doi-asserted-by":"crossref","unstructured":"Ye, J. & DeBose-Boyd, R. A. Regulation of cholesterol and fatty acid synthesis. Cold Spring Harb. Perspect. Biol. 3, 7. https:\/\/cshperspectives.cshlp.org\/content\/3\/7\/a004754.long (2011).","DOI":"10.1101\/cshperspect.a004754"},{"key":"1218_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","volume":"86","author":"D Eberl\u00e9","year":"2004","unstructured":"Eberl\u00e9, D. et al. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86, 839\u2013848 (2004).","journal-title":"Biochimie"},{"key":"1218_CR35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1194\/jlr.M064022","volume":"57","author":"L Vergnes","year":"2016","unstructured":"Vergnes, L. et al. SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression. J. Lipid Rs. 57, 410\u2013421 (2016).","journal-title":"J. Lipid Rs."},{"key":"1218_CR36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.1620506114","volume":"114","author":"HA Ferris","year":"2017","unstructured":"Ferris, H. A. et al. Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc. Natl Acad. Sci. USA 114, 1189\u20131194 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1218_CR37","doi-asserted-by":"publisher","first-page":"S218","DOI":"10.1016\/j.placenta.2011.01.011","volume":"32","author":"LA Woollett","year":"2011","unstructured":"Woollett, L. A. Review: Transport of maternal cholesterol to the fetal circulation. Placenta 32, S218\u2013S221 (2011).","journal-title":"Placenta"},{"key":"1218_CR38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/ajcn\/82.6.1155","volume":"82","author":"LA Woollett","year":"2005","unstructured":"Woollett, L. A. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am. J. Clin. Nutr. 82, 1155\u20131161 (2005).","journal-title":"Am. J. Clin. Nutr."},{"key":"1218_CR39","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0022-2275(20)31601-1","volume":"42","author":"JA McConihay","year":"2001","unstructured":"McConihay, J. A., Horn, P. S. & Woollett, L. A. Effect of maternal hypercholesterolemia on fetal sterol metabolism in the Golden Syrian hamster. J. Lipid Res. 42, 1111\u20131119 (2001).","journal-title":"J. Lipid Res."},{"key":"1218_CR40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1194\/jlr.M600141-JLR200","volume":"47","author":"GS Tint","year":"2006","unstructured":"Tint, G. S. et al. The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J. Lipid Res. 47, 1535\u20131541 (2006).","journal-title":"J. Lipid Res."},{"key":"1218_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000362363","volume":"36","author":"GS Tint","year":"2014","unstructured":"Tint, G. S. et al. Desmosterol in brain is elevated because DHCR24 needs REST for robust expression but REST is poorly expressed. Dev. Neurosci. 36, 132\u2013142 (2014).","journal-title":"Dev. Neurosci."},{"key":"1218_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0022-2275(20)37239-4","volume":"38","author":"HA Jurevics","year":"1997","unstructured":"Jurevics, H. A., Kidwai, F. Z. & Morell, P. Sources of cholesterol during development of the rat fetus and fetal organs. J. Lipid Res. 38, 723\u2013733 (1997).","journal-title":"J. Lipid Res."},{"key":"1218_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","volume":"50","author":"FW Pfrieger","year":"2011","unstructured":"Pfrieger, F. W. & Ungerer, N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 50, 357\u2013371 (2011).","journal-title":"Prog. Lipid Res."},{"key":"1218_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1469-7793.2001.00665.x","volume":"533","author":"K N\u00e4gler","year":"2001","unstructured":"N\u00e4gler, K., Mauch, D. H. & Pfrieger, F. W. Glia-derived signals induce synapse formation in neurones of the rat central nervous system. J. Physiol. 533, 665\u2013679 (2001).","journal-title":"J. Physiol."},{"key":"1218_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1126\/science.291.5504.657","volume":"291","author":"EM Ullian","year":"2001","unstructured":"Ullian, E. M., Sapperstein, S. K., Christopherson, K. S. & Barres, B. A. Control of synapse number by glia. Science 291, 657\u2013661 (2001).","journal-title":"Science"},{"key":"1218_CR46","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/j.1471-4159.1971.tb09604.x","volume":"18","author":"CH Hinse","year":"1971","unstructured":"Hinse, C. H. & Shah, S. N. The desmosterol reductase activity of rat brain during development. J. Neurochem. 18, 1989\u20131998 (1971).","journal-title":"J. Neurochem."},{"key":"1218_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0179-4","volume":"9","author":"S Nie","year":"2014","unstructured":"Nie, S., Chen, G., Cao, X. & Zhang, Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J. Rare Dis. 9, 179 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"1218_CR48","first-page":"385","volume":"147","author":"M Ben Hamida","year":"1991","unstructured":"Ben Hamida, M. et al. Peripheral neuropathy in a sporadic case of cerebrotendinous xanthomatosis. Rev. Neurol. 147, 385\u2013388 (1991).","journal-title":"Rev. Neurol."},{"key":"1218_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJM199401133300205","volume":"330","author":"GS Tint","year":"1994","unstructured":"Tint, G. S. et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330, 107\u2013113 (1994).","journal-title":"N. Engl. J. Med."},{"key":"1218_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0022-3476(95)70261-X","volume":"127","author":"GS Tint","year":"1995","unstructured":"Tint, G. S. et al. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J. Pediatr. 127, 82\u201387 (1995).","journal-title":"J. Pediatr."},{"key":"1218_CR51","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ajmg.c.31343","volume":"160C","author":"MJM Nowaczyk","year":"2012","unstructured":"Nowaczyk, M. J. M. & Irons, M. B. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am. J. Med. Genet. C 160C, 250\u2013262 (2012).","journal-title":"Am. J. Med. Genet. C"},{"key":"1218_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ajmg.a.33148","volume":"152A","author":"E Tierney","year":"2010","unstructured":"Tierney, E., Conley, S. K., Goodwin, H. & Porter, F. D. Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. A 152A, 91\u201395 (2010).","journal-title":"Am. J. Med. Genet. A"},{"key":"1218_CR53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ejhg.2008.10","volume":"16","author":"FD Porter","year":"2008","unstructured":"Porter, F. D. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur. J. Hum. Genet. 16, 535\u2013541 (2008).","journal-title":"Eur. J. Hum. Genet."},{"key":"1218_CR54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI200112103","volume":"108","author":"BU Fitzky","year":"2001","unstructured":"Fitzky, B. U. et al. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz\/RSH syndrome. J. Clin. Invest. 108, 905\u2013915 (2001).","journal-title":"J. Clin. Invest."},{"key":"1218_CR55","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/emboj.2012.31","volume":"31","author":"AO Sodero","year":"2012","unstructured":"Sodero, A. O. et al. Cholesterol loss during glutamate-mediated excitotoxicity. EMBO J. 31, 1764\u20131773 (2012).","journal-title":"EMBO J."},{"key":"1218_CR56","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1111\/bph.13805","volume":"174","author":"AL Catapano","year":"2017","unstructured":"Catapano, A. L., Pirillo, A. & Norata, G. D. Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials. Br. J. Pharm. 174, 3973\u20133985 (2017).","journal-title":"Br. J. Pharm."},{"key":"1218_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0991-6","volume":"14","author":"H Martiskainen","year":"2017","unstructured":"Martiskainen, H. et al. DHCR24 exerts neuroprotection upon inflammation-induced neuronal death. J. Neuroinflamm. 14, 215 (2017).","journal-title":"J. Neuroinflamm."},{"key":"1218_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/01.STR.2.6.587","volume":"2","author":"FM Yatsu","year":"1971","unstructured":"Yatsu, F. M. & Moss, S. A. Brain lipid changes following hypoxia. Stroke 2, 587\u2013593 (1971).","journal-title":"Stroke"},{"key":"1218_CR59","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awz174","volume":"142","author":"R Kacher","year":"2019","unstructured":"Kacher, R. et al. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington\u2019s disease. Brain J. Neurol. 142, 2432\u20132450 (2019).","journal-title":"Brain J. Neurol."},{"key":"1218_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","volume":"115","author":"D del Toro","year":"2010","unstructured":"del Toro, D. et al. Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease. J. Neurochem. 115, 153\u2013167 (2010).","journal-title":"J. Neurochem."},{"key":"1218_CR61","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza, M. et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J. Neurosci. J. Soc. Neurosci. 25, 9932\u20139939 (2005).","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"1218_CR62","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1212\/01.wnl.0000312511.62699.a8","volume":"70","author":"G Hu","year":"2008","unstructured":"Hu, G. et al. Total cholesterol and the risk of Parkinson disease. Neurology 70, 1972\u20131979 (2008).","journal-title":"Neurology"},{"key":"1218_CR63","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1212\/01.wnl.0000247052.18422.e5","volume":"67","author":"G Hu","year":"2006","unstructured":"Hu, G. et al. Body mass index and the risk of Parkinson disease. Neurology 67, 1955\u20131959 (2006).","journal-title":"Neurology"},{"key":"1218_CR64","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2016.10.008","volume":"101","author":"M Doria","year":"2016","unstructured":"Doria, M. et al. Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson\u2019s disease. Free Radic. Biol. Med. 101, 393\u2013400 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"1218_CR65","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/ars.2008.2179","volume":"11","author":"C-YJ Lee","year":"2009","unstructured":"Lee, C.-Y. J. et al. Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke, and Parkinson\u2019s disease patients: cautions in the use of biomarkers of oxidative stress. Antioxid. Redox Signal. 11, 407\u2013420 (2009).","journal-title":"Antioxid. Redox Signal."},{"key":"1218_CR66","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.freeradbiomed.2004.12.008","volume":"38","author":"J-Y Choi","year":"2005","unstructured":"Choi, J.-Y., Jang, E.-H., Park, C.-S. & Kang, J.-H. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Free Radic. Biol. Med. 38, 806\u2013816 (2005).","journal-title":"Free Radic. Biol. Med."},{"key":"1218_CR67","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.nbd.2011.09.009","volume":"45","author":"M Bousquet","year":"2012","unstructured":"Bousquet, M. et al. High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice. Neurobiol. Dis. 45, 529\u2013538 (2012).","journal-title":"Neurobiol. Dis."},{"key":"1218_CR68","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/cdd.2011.105","volume":"19","author":"L Lim","year":"2012","unstructured":"Lim, L. et al. Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson\u2019s disease. Cell Death Differ. 19, 416\u2013427 (2012).","journal-title":"Cell Death Differ."},{"key":"1218_CR69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1517\/13543784.2015.1021919","volume":"24","author":"Y Xiong","year":"2015","unstructured":"Xiong, Y., Zhang, Y., Mahmood, A. & Chopp, M. Investigational agents for treatment of traumatic brain injury. Expert Opin. Investig. Drugs 24, 743\u2013760 (2015).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"1218_CR70","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.injury.2007.10.005","volume":"38","author":"MC Morganti-Kossmann","year":"2007","unstructured":"Morganti-Kossmann, M. C., Satgunaseelan, L., Bye, N. & Kossmann, T. Modulation of immune response by head injury. Injury 38, 1392\u20131400 (2007).","journal-title":"Injury"},{"key":"1218_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23959-2","volume":"8","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Traumatic brain injury leads to accelerated atherosclerosis in apolipoprotein E deficient mice. Sci. Rep. 8, 5639 (2018).","journal-title":"Sci. Rep."},{"key":"1218_CR72","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/02699050802196037","volume":"22","author":"MF Weiner","year":"2008","unstructured":"Weiner, M. F. et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. Brain Inj. 22, 611\u2013615 (2008).","journal-title":"Brain Inj."},{"key":"1218_CR73","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbalip.2015.02.010","volume":"1851","author":"G Saher","year":"2015","unstructured":"Saher, G. & Stumpf, S. K. Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim. Biophys. Acta 1851, 1083\u20131094 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"1218_CR74","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuropharm.2014.05.027","volume":"85","author":"AJ Linsenbardt","year":"2014","unstructured":"Linsenbardt, A. J. et al. Different oxysterols have opposing actions at N-methyl-D-aspartate receptors. Neuropharmacology 85, 232\u2013242 (2014).","journal-title":"Neuropharmacology"},{"key":"1218_CR75","first-page":"E424","volume":"304","author":"JC Jun","year":"2013","unstructured":"Jun, J. C. et al. Thermoneutrality modifies the impact of hypoxia on lipid metabolism. Am. J. Physiol. 304, E424\u2013E435 (2013).","journal-title":"Am. J. Physiol."},{"key":"1218_CR76","doi-asserted-by":"publisher","first-page":"254076","DOI":"10.1155\/2015\/254076","volume":"2015","author":"NM Denihan","year":"2015","unstructured":"Denihan, N. M., Boylan, G. B. & Murray, D. M. Metabolomic profiling in perinatal asphyxia: a promising new field. BioMed. Res. Int. 2015, 254076 (2015).","journal-title":"BioMed. Res. Int."},{"key":"1218_CR77","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","volume":"17","author":"N Fabelo","year":"2011","unstructured":"Fabelo, N. et al. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson\u2019s disease and incidental Parkinson\u2019s disease. Mol. Med. 17, 1107\u20131118 (2011).","journal-title":"Mol. Med."},{"key":"1218_CR78","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3940(02)00164-7","volume":"324","author":"P Sch\u00f6nknecht","year":"2002","unstructured":"Sch\u00f6nknecht, P. et al. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer\u2019s disease compared to healthy controls. Neurosci. Lett. 324, 83\u201385 (2002).","journal-title":"Neurosci. Lett."},{"key":"1218_CR79","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","volume":"11","author":"A Papassotiropoulos","year":"2000","unstructured":"Papassotiropoulos, A. et al. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer\u2019s disease. NeuroReport 11, 1959\u20131962 (2000).","journal-title":"NeuroReport"},{"key":"1218_CR80","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1194\/jlr.M022376","volume":"53","author":"Y Sato","year":"2012","unstructured":"Sato, Y. et al. Identification of a new plasma biomarker of Alzheimer\u2019s disease using metabolomics technology. J. Lipid Res. 53, 567\u2013576 (2012).","journal-title":"J. Lipid Res."},{"key":"1218_CR81","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2302\/kjm.19.145","volume":"19","author":"H Wakamatsu","year":"1970","unstructured":"Wakamatsu, H. et al. Serum desmosterol and other lipids in myotonic dystrophy-a possible pathogenesis of myotonic dystrophy. Keio J. Med. 19, 145\u2013149 (1970).","journal-title":"Keio J. Med."},{"key":"1218_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14241","volume":"8","author":"SA Berghoff","year":"2017","unstructured":"Berghoff, S. A. et al. Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nat. Commun. 8, 14241 (2017).","journal-title":"Nat. Commun."},{"key":"1218_CR83","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.wneu.2019.08.250","volume":"132","author":"AJ Chong","year":"2019","unstructured":"Chong, A. J. et al. The neuroprotective effects of simvastatin on high cholesterol following traumatic brain injury in rats. World Neurosurg. 132, e99\u2013e108 (2019).","journal-title":"World Neurosurg."},{"key":"1218_CR84","first-page":"783","volume":"144","author":"DM Sikora","year":"2004","unstructured":"Sikora, D. M. et al. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome. J. Pediatr. 144, 783\u2013791 (2004).","journal-title":"J. Pediatr."},{"key":"1218_CR85","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","volume":"344","author":"PM Ridker","year":"2001","unstructured":"Ridker, P. M. et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 344, 1959\u20131965 (2001).","journal-title":"N. Engl. J. Med."},{"key":"1218_CR86","first-page":"62","volume":"7","author":"EF Wible","year":"2010","unstructured":"Wible, E. F. & Laskowitz, D. T. Statins in traumatic brain injury. Neurother. J. Am. Soc. Exp. Neurother. 7, 62\u201373 (2010).","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"1218_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0934-2","volume":"14","author":"X Xu","year":"2017","unstructured":"Xu, X. et al. Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury. J. Neuroinflamm. 14, 167 (2017).","journal-title":"J. Neuroinflamm."},{"key":"1218_CR88","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/01.jnen.0000225906.82428.69","volume":"65","author":"X He","year":"2006","unstructured":"He, X. et al. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J. Neuropathol. Exp. Neurol. 65, 652\u2013663 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1218_CR89","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/gim.2016.102","volume":"19","author":"CA Wassif","year":"2017","unstructured":"Wassif, C. A. et al. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome. Genet. Med. 19, 297\u2013305 (2017).","journal-title":"Genet. Med."},{"key":"1218_CR90","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0022-2275(20)33442-8","volume":"41","author":"PE Jira","year":"2000","unstructured":"Jira, P. E. et al. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome. J. Lipid Res. 41, 1339\u20131346 (2000).","journal-title":"J. Lipid Res."},{"key":"1218_CR91","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0026-0495(99)90040-9","volume":"48","author":"A Verrips","year":"1999","unstructured":"Verrips, A. et al. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. Metabolism 48, 233\u2013238 (1999).","journal-title":"Metabolism"},{"key":"1218_CR92","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1161\/hs0901.094287","volume":"32","author":"W Balduini","year":"2001","unstructured":"Balduini, W., De Angelis, V., Mazzoni, E. & Cimino, M. Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic\/ischemic brain injury. Stroke 32, 2185\u20132191 (2001).","journal-title":"Stroke"},{"key":"1218_CR93","doi-asserted-by":"publisher","first-page":"113117","DOI":"10.1016\/j.expneurol.2019.113117","volume":"324","author":"S Carloni","year":"2020","unstructured":"Carloni, S. & Balduini, W. Simvastatin preconditioning confers neuroprotection against hypoxia-ischemia induced brain damage in neonatal rats via autophagy and silent information regulator 1 (SIRT1) activation. Exp. Neurol. 324, 113117 (2020).","journal-title":"Exp. Neurol."},{"key":"1218_CR94","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1179\/016164110X12670144737774","volume":"32","author":"A Li","year":"2010","unstructured":"Li, A. et al. Simvastatin attenuates hypomyelination induced by hypoxia-ischemia in neonatal rats. Neurol. Res. 32, 945\u2013952 (2010).","journal-title":"Neurol. Res."},{"key":"1218_CR95","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.brainres.2009.08.037","volume":"1298","author":"S Rufini","year":"2009","unstructured":"Rufini, S. et al. Cholesterol depletion inhibits electrophysiological changes induced by anoxia in CA1 region of rat hippocampal slices. Brain Res. 1298, 178\u2013185 (2009).","journal-title":"Brain Res"},{"key":"1218_CR96","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1161\/01.STR.0000080677.24419.88","volume":"34","author":"W Balduini","year":"2003","unstructured":"Balduini, W. et al. Prophylactic but not delayed administration of simvastatin protects against long-lasting cognitive and morphological consequences of neonatal hypoxic-ischemic brain injury, reduces interleukin-1beta and tumor necrosis factor-alpha mRNA induction, and does not affect endothelial nitric oxide synthase expression. Stroke 34, 2007\u20132012 (2003).","journal-title":"Stroke"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01218-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01218-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T23:13:08Z","timestamp":1635203588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01218-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-01218-3","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}